BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang F, Zhang F, Xu D, Zhang Z, Xu F, Tao X, Qiu L, Wei H. Enterococcus faecium WEFA23 from infants lessens high-fat-diet-induced hyperlipidemia via cholesterol 7-alpha-hydroxylase gene by altering the composition of gut microbiota in rats. J Dairy Sci 2018;101:7757-67. [PMID: 29935822 DOI: 10.3168/jds.2017-13713] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 dos Santos VR, de Carvalho GO, Silva JBNF. Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit Environments. Microbiology Research 2021;12:553-66. [DOI: 10.3390/microbiolres12030039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Iglesias-Carres L, Hughes MD, Steele CN, Ponder MA, Davy KP, Neilson AP. Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation. J Nutr Biochem 2021;91:108600. [PMID: 33577949 DOI: 10.1016/j.jnutbio.2021.108600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Liu Y, Chen X, Zhao W, Lang M, Zhang X, Wang T, Farouk MH, Zhen Y, Qin G. Effects of yeast culture supplementation and the ratio of non-structural carbohydrate to fat on rumen fermentation parameters and bacterial-community composition in sheep. Animal Feed Science and Technology 2019;249:62-75. [DOI: 10.1016/j.anifeedsci.2019.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Yang S, Li D, Yu Z, Li Y, Wu M. Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. Front Pharmacol 2021;12:709629. [PMID: 34305616 DOI: 10.3389/fphar.2021.709629] [Reference Citation Analysis]
5 Liang X, Zhang Z, Lv Y, Tong L, Liu T, Yi H, Zhou X, Yu Z, Tian X, Cui Q, Yang J, Gong P, Zhang L. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis. Nutrition 2020;79-80:110941. [PMID: 32858376 DOI: 10.1016/j.nut.2020.110941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Dapkevicius MLE, Sgardioli B, Câmara SPA, Poeta P, Malcata FX. Current Trends of Enterococci in Dairy Products: A Comprehensive Review of Their Multiple Roles. Foods 2021;10:821. [PMID: 33920106 DOI: 10.3390/foods10040821] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
7 Chan MM, Yang X, Wang H, Saaoud F, Sun Y, Fong D. The Microbial Metabolite Trimethylamine N-Oxide Links Vascular Dysfunctions and the Autoimmune Disease Rheumatoid Arthritis. Nutrients 2019;11:E1821. [PMID: 31394758 DOI: 10.3390/nu11081821] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
8 Chen CY, Leu HB, Wang SC, Tsai SH, Chou RH, Lu YW, Tsai YL, Kuo CS, Huang PH, Chen JW, Lin SJ. Inhibition of Trimethylamine N-oxide attenuates neointimal formation through reduction of inflammasome and oxidative stress in a mouse model of carotid artery ligation. Antioxid Redox Signal 2022. [PMID: 35713239 DOI: 10.1089/ars.2021.0115] [Reference Citation Analysis]
9 Yang S, Li X, Yang F, Zhao R, Pan X, Liang J, Tian L, Li X, Liu L, Xing Y, Wu M. Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target. Front Pharmacol 2019;10:1360. [PMID: 31803054 DOI: 10.3389/fphar.2019.01360] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 16.0] [Reference Citation Analysis]
10 Wei M, Gu E, Luo J, Zhang Z, Xu D, Tao X, Shah NP, Wei H. Enterococcus hirae WEHI01 isolated from a healthy Chinese infant ameliorates the symptoms of type 2 diabetes by elevating the abundance of Lactobacillales in rats. J Dairy Sci 2020;103:2969-81. [PMID: 32059859 DOI: 10.3168/jds.2019-17185] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Vourakis M, Mayer G, Rousseau G. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis. Int J Mol Sci 2021;22:8074. [PMID: 34360839 DOI: 10.3390/ijms22158074] [Reference Citation Analysis]
12 Zeng Z, Zhou Y, Xu Y, Wang S, Wang B, Zeng Z, Wang Q, Ye X, Jin L, Yue M, Tang L, Zou P, Zhao P, Li W. Bacillus amyloliquefaciens SC06 alleviates the obesity of ob/ob mice and improves their intestinal microbiota and bile acid metabolism. Food Funct 2022;13:5381-95. [PMID: 35470823 DOI: 10.1039/d1fo03170h] [Reference Citation Analysis]
13 Tang J, Qin M, Tang L, Shan D, Zhang C, Zhang Y, Wei H, Qiu L, Yu J. Enterobacter aerogenes ZDY01 inhibits choline-induced atherosclerosis through CDCA-FXR-FGF15 axis. Food Funct 2021;12:9932-46. [PMID: 34492674 DOI: 10.1039/d1fo02021h] [Reference Citation Analysis]
14 Pushpass RG, Alzoufairi S, Jackson KG, Lovegrove JA. Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods. Nutr Res Rev 2021;:1-20. [PMID: 33926590 DOI: 10.1017/S0954422421000081] [Reference Citation Analysis]